PR Newswire February 26, 2020
KPMG LLP

NEW YORK — While there is a great deal of hype and potential about artificial intelligence (AI) as a tool in medicine, only 36% of U.S. business decision makers in healthcare say their organizations have a code of ethics for this technology – the lowest among the five industries surveyed by KPMG LLP.

Another 21% of healthcare leaders with at least a moderate knowledge of AI said their organizations were in the process of developing a code of ethics for the use of AI, trailing the five-industry average of 31%.

Living in an AI World: Achievements and Challenges in Artificial Intelligence across Five Industries, a survey of 750 U.S. business decision makers about AI, found that 88% of respondents –...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Market Research, Technology, Trends
Microsoft supercharges Fabric with new data tools to accelerate enterprise AI workflows
Citizen Health Secures $14.5M for AI Platform for Rare Diseases
Microsoft and C3 AI Expand Partnership to Promote Enterprise AI
What Gen Z thinks about AI and work: LinkedIn
Jimini Health Launches with $8M for AI Therapist Assistant, Sage

Share This Article